Second quarter revenues remained flat at $8.4 million for Clean Diesel Technologies compared to 2016 but net losses increased to $385,000. The Oxnard-based company makes emissions control technology for diesel vehicles. A cost cutting initiative helped bring operating expenses down to $2.3 million for the quarter ended June 30, less than half what they were Read More →
Amgen’s new leukemia drug cured 39 percent of pediatric patients who received treatment, the Thousand Oaks company said Oct. 3 after publishing results of a new study in the Journal of Clinical Oncology. Blincyto, which treats a rare form of the disease known as precursor B-cell acute lymphoblastic leukemia, sent 27 patients out of 70 Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.